Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil(Public Health Agency of Sweden), Josef Penninger(Helmholtz Centre for Infection Research), Felipe Prósper(Institute of Human Genetics), Alì Mirazimi(Public Health Agency of Sweden), Gerald Wirnsberger(Vienna Biocenter), Patricia Prado(Institute for Bioengineering of Catalonia), Núria Montserrat(Institució Catalana de Recerca i Estudis Avançats), Astrid Hagelkrüys(Institute of Molecular Biotechnology), Reiner Wimmer(Austrian Academy of Sciences), Arthur S. Slutsky(St. Michael's Hospital), Elena Garreta(Institute for Bioengineering of Catalonia), Alexandra Leopoldi(Institute of Molecular Biotechnology), Carmen Hurtado del Pozo(NYU Langone Health), Hyesoo Kwon(Swedish Veterinary Agency), Martin Ståhl(Roche (Switzerland)), Haibo Zhang(St. Michael's Hospital), Juan P. Romero(Universidad de Navarra), Ryan Conder(Stemcell Technologies)
Cited by 2,261
Related Papers
Cerebral organoids model human brain development and microcephaly
|Nature|2013|5.4k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A Medicinal Chemist’s Guide to Molecular Interactions
|Journal of Medicinal Chemistry|2010|1.7k
Molecular definitions of autophagy and related processes
|The EMBO Journal|2017|1.6k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k